G1 Therapeutics (GTHX) and Pharmacosmos Group Announce Expiration of Hart-Scott-Rodino Waiting Period Sep 5, 2024 06:31AM
G1 Therapeutics, Inc. (GTHX) Tops Q2 EPS by 7c, reaffirms guidance Aug 8, 2024 06:33AM
G1 Therapeutics (GTHX) Acquired by Pharmacosmos Group for $7.15/sh Cash or $405M Aug 7, 2024 06:30AM
G1 Therapeutics (GTHX) PT Lowered to $6 at Needham Jun 25, 2024 07:06AM
G1 Therapeutics (GTHX) PT Lowered to $3 at H.C. Wainwright Jun 25, 2024 06:42AM


Jun 24, 2024 10:43AM TD Cowen Reiterates Buy Rating on G1 Therapeutics (GTHX)
Jun 24, 2024 06:31AM G1 Therapeutics (GTHX) Provides Update on Phase 3 PRESERVE 2 Trial